J. Lipid Res.  Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on February 1, 2004

Papers In Press, published online ahead of print October 27, 2003
J. Lipid Res., doi:10.1194/jlr.M300104-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M300104-JLR200v4
45/2/366    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lapierre, L. R.
Right arrow Articles by McLeod, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lapierre, L. R.
Right arrow Articles by McLeod, R. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on March 6, 2003
Revised on August 13, 2003
Accepted on October 27, 2003

Amino acid sequences within the beta 1 domain of human apolipoprotein B can mediate rapid intracellular degradation

Louis R. Lapierre, Deborah L. Currie, Zemin Yao, Jianjun Wang, and Roger S. McLeod

Biochemistry and Molecular Biology, Dalhousie University, Halifax, Nova Scotia B3H 1X8

Corresponding Author: rmcleod2{at}dal.ca

Apolipoprotein (apo) B48 contains a region (between the carboxyl termini of apo-B22 to –B43) termed the b1 domain that is predicted to be composed of extensive amphipathic b-strands. Pulse-chase analysis of truncated apoB variants revealed that sequences between the carboxyl termini of apo-B37 and -B42 governed the secretion efficiency and intracellular stability of apoB. Thus, while apo-B37, –B34 and –B29 were stable and secreted efficiently, –B42 and –B100 were secreted poorly and were sensitive to degradation. Degradation of –B42 and –B100 could be partially inhibited by the proteasome inhibitor ALLN. Amino acid sequence analysis suggested that a segment encompassing amino acid residues 1724 to 1921 of human apoB (i.e. between the carboxyl termini of apo-B38.0 and –B42.4) was 34% identical and 63% homologous to fatty acid binding proteins, for which crystal structures reveal orthogonal b-sheet structures. To test the hypothesis that sequences from the b1 are involved in apoB degradation, fusion proteins were created that contained apoB29 linked either to fragments derived from the b1 domain of apoB, namely B34-42, B34-37, or B37-42, or to the liver fatty acid binding protein. In transfected cells, the fusion proteins containing the b1 domain segments B34-42 or B37-42 exhibited rapid intracellular degradation, but the fusion proteins containing liver fatty acid binding protein or B34-37 were stable and secreted efficiently. Degradation of fusion proteins containing B34-42 or B37-42 could be blocked by ALLN, and the presence of B34-42 increased the association of the apoB protein with the cytosolic surface of the microsomal membrane. Thus, our data suggest that the presence of specific sequences in the b1 domain of human apoB increases the susceptibility of the protein to rapid intracellular degradation by promoting exposure of the protein to the cytosol, but that not all regions of the b1 domain are functionally equivalent.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
E. A. Fisher, L. R. Lapierre, R. D. Junkins, and R. S. McLeod
The AAA-ATPase p97 facilitates degradation of apolipoprotein B by the ubiquitin-proteasome pathway
J. Lipid Res., October 1, 2008; 49(10): 2149 - 2160.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. R. Burnett, S. Zhong, Z. G. Jiang, A. J. Hooper, E. A. Fisher, R. S. McLeod, Y. Zhao, P. H. R. Barrett, R. A. Hegele, F. M. van Bockxmeer, et al.
Missense Mutations in APOB within the beta{alpha}1 Domain of Human APOB-100 Result in Impaired Secretion of ApoB and ApoB-containing Lipoproteins in Familial Hypobetalipoproteinemia
J. Biol. Chem., August 17, 2007; 282(33): 24270 - 24283.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. J. Whitfield, P. H. R. Barrett, F. M. van Bockxmeer, and J. R. Burnett
Lipid Disorders and Mutations in the APOB Gene
Clin. Chem., October 1, 2004; 50(10): 1725 - 1732.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.